Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Hirokuni, Hirata"'
Autor:
Sakura Sato, Noriyuki Yanagida, Komei Ito, Yoshitaka Okamoto, Hirohisa Saito, Masami Taniguchi, Makoto Nagata, Hirokuni Hirata, Masao Yamaguchi, Ruby Pawankar, Motohiro Ebisawa
Publikováno v:
Allergology International, Vol 72, Iss 3, Pp 437-443 (2023)
Background: Anaphylaxis is a potentially fatal severe systemic hypersensitivity reaction that causes symptoms in multiple organs such as the skin, respiratory tract, and gastrointestinal tract; however, no nationwide epidemiological survey on anaphyl
Externí odkaz:
https://doaj.org/article/892a1f2011164ac69dfdd9d2b454b055
Autor:
Hisanori Hirokawa, Hirokuni Hirata, Hayase Azuma, Kei Sugitate, Sayo Soda, Jun Matsushima, Yasutsugu Fukushima
Publikováno v:
Respiratory Medicine Case Reports, Vol 51, Iss , Pp 102094- (2024)
There is no established treatment for lung adenocarcinoma with uncommon/compound epidermal growth factor receptor (EGFR) mutations. We report a case of a 73-year-old man with stage IVB lung adenocarcinoma harboring E709G and L861Q EGFR mutations. Aft
Externí odkaz:
https://doaj.org/article/19c2fec20eac4306851054f2104beb36
Autor:
Ryosuke Souma, Kumiya Sugiyama, Hiroyuki Masuda, Hajime Arifuku, Kentaro Nakano, Hiroyoshi Watanabe, Tomoshige Wakayama, Shingo Tokita, Masamitsu Tatewaki, Hideyuki Satoh, Kenya Koyama, Yumeko Hayashi, Fumiya Fukushima, Hirokuni Hirata, Masafumi Arima, Kazuhiro Kurasawa, Takeshi Fukuda, Yasutsugu Fukushima
Publikováno v:
Asthma Research and Practice, Vol 4, Iss 1, Pp 1-8 (2018)
Abstract Background The combination of budesonide + formoterol (BFC) offers the advantages of dose adjustment in a single inhaler according to asthma symptoms. We analyzed the relationship between asthma symptoms in terms of peak expiratory flow (PEF
Externí odkaz:
https://doaj.org/article/2d6d697ec686455ba5e79d5238ec90fa
Autor:
Hisanori, Hirokawa, Hirokuni, Hirata, Ryo, Kitajima, Masahira, Irokawa, Tomoyuki, Ishiguro, Tomoki, Hasegawa, Junya, Sato, Atsutaka, Ozaki, Masafumi, Arima, Shinji, Teramoto, Kosuke, Haruki, Takamitsu, Okamura, Hideto, Tamura, Koshi, Hashimoto, Yasutsugu, Fukushima
Publikováno v:
Dokkyo Medical Journal. 1(2):141-146
The patient was a 68-year-old woman who was hospitalized for SARS-CoV-2 pneumonia while receiving chemotherapy for B-cell lymphoma. She experienced repeated episodes of pneumonia that temporarily went into remission with steroid and remdesivir and bu
Autor:
Hirokuni Hirata, Naruo Yoshida, Masamitsu Tatewaki, Sadaaki Shiromori, Kozo Sato, Tomoshige Wakayama, Shingo Tokita, Kumiya Sugiyama, Masafumi Arima, Kazuhiro Kurasawa, Takeshi Fukuda, Daisuke Shima, Yasutsugu Fukushima
Publikováno v:
Allergology International, Vol 67, Iss 1, Pp 153-155 (2018)
Externí odkaz:
https://doaj.org/article/70387619d89f431ab05b637bfe4acf06
Autor:
Masamitsu Tatewaki, Hirokuni Hirata, Yoshihiko Ikeno, Ikuo Akutsu, Seiko Sekiguchi, Natsumi Suzuki, Kumiya Sugiyama, Masafumi Arima, Kazuhiro Kurasawa, Takeshi Fukuda, Daisuke Shima, Yasutsugu Fukushima
Publikováno v:
Allergology International, Vol 65, Iss 4, Pp 483-486 (2016)
Externí odkaz:
https://doaj.org/article/a4ccc8119aa5428a8cca6b9186f880e6
Autor:
Kenya Koyama, Hirokuni Hirata, Shingo Tokita, Masafumi Arima, Yasutsugu Fukushima, Hajime Arifuku, Naotatsu Otsuji, Kazuhiro Kurasawa, Hiroyoshi Watanabe, Kumiya Sugiyama, Tomoshige Wakayama, Kentaro Nakano
Publikováno v:
Asian Pacific Journal of Allergy and Immunology.
Background Inhaled corticosteroids (ICS) are a safe treatment for asthma. However, at higher doses, ICS use has been reported to inhibit adrenocortical function. Objective This study aimed to evaluate the effect of ICS on bone mineral density (BMD) i
Autor:
Hiromichi Inoue, Jun Matsushima, Satoru Kobayashi, Toshimi Sairenchi, Hirokuni Hirata, Masayuki Chida, Satoshi Ota, Shinichi Ban, Yuji Matsumura
Publikováno v:
International Journal of Surgical Pathology. 30:151-159
Small cell lung carcinoma (SCLC) and pulmonary large cell neuroendocrine carcinoma (LCNEC) are both classified as lung neuroendocrine carcinoma (NEC). It has recently been reported that the special AT-rich sequence-binding protein 2 (STAB2), known as
Autor:
Hirokuni Hirata, Masamitsu Tatewaki, Sadaaki Shiromori, Yoshihiko Ikeno, Ikuo Akutsu, Kumiya Sugiyama, Masafumi Arima, Kazuhiro Kurasawa, Takeshi Fukuda, Daisuke Shima, Yasutsugu Fukushima
Publikováno v:
Allergology International, Vol 66, Iss 1, Pp 149-151 (2017)
Externí odkaz:
https://doaj.org/article/2cb47a725b264ae997f2fa0e56d9a8cb
Autor:
Takashi Ogasawara, Yuko Kohashi, Jun Ikari, Toshibumi Taniguchi, Nobuhide Tsuruoka, Haruko Watanabe-Takano, Lisa Fujimura, Akemi Sakamoto, Masahiko Hatano, Hirokuni Hirata, Yasutsugu Fukushima, Takeshi Fukuda, Kazuhiro Kurasawa, Koichiro Tatsumi, Takeshi Tokuhisa, Masafumi Arima
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Transcriptional repressor B-cell lymphoma 6 (Bcl6) appears to regulate TH2 immune responses in allergies, but its precise role is unclear. We previously reported that Bcl6 suppressed IL-4 production in naïve CD4+ T cell-derived memory TH2 cells. To
Externí odkaz:
https://doaj.org/article/d2fd1e26406c41e19cd9be331a9172e4